Brain retraining trial aims to ease chronic fatigue and long COVID symptoms
NCT ID NCT06933173
First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 2 times
Summary
This study is testing a mind-body program called DNRS for people with ME/CFS (chronic fatigue syndrome) who may also have Long COVID. The program uses brain retraining to help calm overactive nerves and improve symptoms like fatigue, pain, and mood. Researchers will track quality of life, daily activity, and sleep in 200 adults over several months to see if the program works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older; * Individuals diagnosed with ME/CFS, according to the Institute of Medicine (2015) criteria, for more than six months. Exclusion Criteria: Individuals who: 1) are too ill to participate; 2) lack reliable internet; 3) cannot communicate in English; 4) Presently have or ever had inflammatory bowel disease; and/or 5) Have been prescribed or used an oral or systemic (infusion) antibiotic in the past one month-;; 6) are participating in a concurrent study; 7) are participating in a concurrent mind-body intervention during the study period including * Art Therapy * Autogenic training * Biofeedback/neurofeedback * Breathing exercise * Cognitive restructuring * Dynamic Neural Retraining System * Emotional Freedom Techniques (EFT) * Eye movement desensitization and reprocessing (EMDR) * Guided imagery * Hypnotherapy/self-hypnosis * Meditation (mindfulness, mantra, guided, transcendental) * Mindfulness-based cognitive therapy (MBCT) * Mindfulness-based Stress Reduction (MBSR) * Music therapy * Neurolinguistic programming * Psychological flexibility * Qigong * Relaxation therapy (relaxation response, progressive muscle relaxation) * Tai Chi * Visualization * Yoga and/or starting any other new treatment during the study period, including any mind-body therapy, psychotherapy, prescription medication, over-the-counter medication, etc; 8) have any active medical condition (untreated/uncontrolled) that may explain the presence of fatigue including: * untreated hypothyroidism (including Hashimoto's disease) * hyperthyroidism * diabetes mellitus * iron deficiency anemia * other treatable anemia * iron overload syndrome * adrenal insufficiency * Cushing's syndrome * anorexia nervosa * iatrogenic conditions such as side effects or interactions of medication(s) or supplements • Rheumatological disorders: * rheumatoid arthritis * lupus * polymyositis * polymyalgia rheumatica * Sjogren's Syndrome * Ehlers Danlos Syndromes \[Hypermobility type\] • Other heritable disorders of connective tissue: * Marfan syndrome * Stickler syndrome etc. * Multiple sclerosis * Celiac disease * Note: Patients with celiac disease can present without gastrointestinal symptoms • Immune disorders * such as HIV/AIDS • Sleep disorders * including obstructive sleep apnea • Prior illnesses may relapse or may not have completely resolved during treatment. * Examples are certain malignancies * leukemia * infectious diseases such as tuberculosis and chronic hepatitis • Active primary psychiatric disorders * eating disorders * alcohol * substance use disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Myalgic encephalomyelitis/chronic fatigue syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Peter Lougheed Hospital
RECRUITINGCalgary, Alberta, Canada
-
University of Alberta Hospital/Kaye Edmonton Clinic
RECRUITINGEdmonton, Alberta, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a High-Fat diet reset energy in long COVID?
- Scientists probe the mysterious crash that defines ME/CFS
- Acupuncture needles aim to clear COVID brain fog in new trial
- Could a tiny dose of naltrexone ease ME/CFS fatigue?
- Scientists launch study to uncover what drives chronic fatigue syndrome
- Fatigue study seeks to unravel mystery of exhaustion